Dr. Knelson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Merck Research Labs
Boston, MA 02115
Summary
- Erik Knelson, MD, is a Boston-based oncologist with expertise in internal medicine. He completed his residency in Internal Medicine at Brigham and Women's Hospital and is a graduate of Duke University School of Medicine. Dr. Knelson currently works as a Clinical Director at Merck. He formerly cared for patients at Dana-Farber Cancer Institute, Massachusetts General Physicians Organization and Spaulding Hospital for Continuing Medical Care Cambridge. He has published several research papers related to oncology, notably lung cancer, with some gaining multiple citations in other works.
Education & Training
Brigham and Women's HospitalResidency, Internal Medicine, 2015 - 2017
Duke University School of MedicineClass of 2015
Certifications & Licensure
MA State Medical License 2015 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer.Takahiko Murayama, Navin R Mahadevan, Catherine B Meador, Elena V Ivanova, Yuqiao Pan
Cancer Research Communications. 2024-09-01 - 6 citationsThe germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells.Christopher Noyes, Shunsuke Kitajima, Fengkai Li, Yusuke Suita, Saradha Miriyala
Communications Biology. 2023-01-18 - 14 citationsMET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer.Ryohei Yoshida, Maria Saigi, Tetsuo Tani, Benjamin F Springer, Hirofumi Shibata
Cancer Research. 2022-11-02
Authored Content
- Type III TGF-Β Receptor Promotes FGF2-Mediated Neuronal Differentiation in NeuroblastomaOctober 2013
Press Mentions
Drs. Erik Knelson, Dwight Owen, and Erin Schenk Receive 10th Annual LUNGevity Career Development AwardsSeptember 16th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
